Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience

被引:13
|
作者
Nishijima, Haruo [1 ,2 ]
Ueno, Tatsuya [1 ,2 ]
Kon, Tomoya [1 ]
Haga, Rie [1 ]
Funamizu, Yukihisa [1 ]
Arai, Akira [1 ]
Suzuki, Chieko [1 ]
Nunomura, Jin-ichi [1 ]
Baba, Masayuki [1 ]
Tomiyama, Masahiko [1 ,2 ]
机构
[1] Aomori Prefectural Cent Hosp, Dept Neurol, 2-1-1 Higashi Tsukurimichi, Aomori 0308553, Japan
[2] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neurophysiol, Hirosaki, Aomori, Japan
关键词
Duloxetine; Dyskinesia; Norepinephrine transporter; OFF time; Serotonin transporter; Parkinson's disease; L-DOPA; LEVODOPA; DEPRESSION; CITALOPRAM; DYSKINESIA; STRIATUM; REUPTAKE; MODEL;
D O I
10.1016/j.jns.2017.01.066
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:186 / 189
页数:4
相关论文
共 50 条
  • [21] Using gait robotics to improve symptoms of parkinson's disease: an open-label, pilot randomized controlled trial
    Gryfe, Pearl
    Sexton, Andrew
    Mcgibbon, Chris A.
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2022, 58 (05) : 723 - 737
  • [22] An open-label trial of olanzapine for corticosteroid-induced mood symptoms
    Brown, ES
    Chamberlain, W
    Dhanani, N
    Paranjpe, P
    Carmody, TJ
    Sargeant, M
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 83 (2-3) : 277 - 281
  • [23] An open-label trial of olanzapine for corticosteroid-induced mood symptoms
    Brown, ES
    Chamberlain, W
    Dhanani, N
    Paranjpe, P
    Sargeant, M
    PSYCHOSOMATICS, 2004, 45 (02) : 147 - 148
  • [24] S-adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial
    Di Rocco, A
    Rogers, JD
    Brown, R
    Werner, P
    Bottiglieri, T
    MOVEMENT DISORDERS, 2000, 15 (06) : 1225 - 1229
  • [25] Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
    Heinz Reichmann
    Andrew Lees
    José-Francisco Rocha
    Diogo Magalhães
    Patrício Soares-da-Silva
    Translational Neurodegeneration, 9
  • [26] Short-term motor effects of riluzole in Huntington's disease: An open-label study
    Granata, R
    Seppi, K
    Mueller, J
    Poewe, W
    Wenning, G
    MOVEMENT DISORDERS, 2002, 17 : S324 - S324
  • [27] Effects of sildenafil on motor symptoms in Parkinson's disease
    Winge, K.
    Friberg, L.
    Werdelin, L.
    Stimpel, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 256 - 256
  • [28] Effects of Clairvee® oral probiotic supplementation on women's vaginal symptoms in an open-label experience trial
    Kellogg, Susan
    Faught, Brooke
    Krychman, Michael
    Bernsley, Devon
    Sylla, Sarah
    Dweck, Alyssa
    Komorowski, James
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (12): : 1471 - 1472
  • [29] Pilates method improves balance control in Parkinson's disease patients: An open-label clinical trial
    Maciel, David Pereira
    Mesquita, Vivia Linhares
    Marinho, Antonia Rosivalda
    Ferreira, Glauber Menezes
    Abdon, Ana Paula
    Martins, Fernanda
    PARKINSONISM & RELATED DISORDERS, 2020, 77 : 18 - 19
  • [30] Effects of nilotinib on safety in open-label phase I clinical trial in Parkinson's disease with dementia and Lewy body dementia
    Pagan, F.
    Valadez, E.
    Torres-Yaghi, Y.
    Falconer, R.
    Mills, R.
    Rogers, S.
    Wilmarth, B.
    Hebron, M.
    Moussa, C.
    MOVEMENT DISORDERS, 2016, 31 : S636 - S636